Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Naoya Minami
Observed names:
N Minami,
N. Minami
Institution:
National Hospital Organization Hokkaido Medical Center
Observed institutions:
Tokyo Medical University,
Chiba University,
Keio University,
Hokkaido University,
Toho University Ohashi Medical Center,
National Hospital Organization Hokkaido Medical Center,
Sapporo Minami Hospital,
National Hospital Organization,
The University of Osaka
show all 9
ORCID:
0009-0002-4971-9609
Observed ORCID:
0009-0002-4971-9609
OpenAlex ID:
A5038217907
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study
2023
·
James F Howard
, Saskia Bresch
, et al.
·
The Lancet Neurology
·
308
Early fast‐acting treatment strategy against generalized myasthenia gravis
2016
·
Kimiaki Utsugisawa
, Yuriko Nagane
, et al.
·
Muscle & Nerve
·
83
PDF
Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study
2017
·
Yuriko Nagane
, Hiroyuki Murai
, et al.
·
BMJ Open
·
80
Suppressed pro-inflammatory properties of circulating B cells in patients with multiple sclerosis treated with fingolimod, based on altered proportions of B-cell subpopulations
2014
·
Yusei Miyazaki
, Masaaki Niino
, et al.
·
Clinical Immunology
·
63
Effectiveness of early cycles of fast-acting treatment in generalised myasthenia gravis
2023
·
Akiyuki Uzawa
, Shigeaki Suzuki
, et al.
·
Journal of Neurology Neurosurgery & Psychiatry
·
54
Response to treatment of myasthenia gravis according to clinical subtype
2016
·
Tetsuya Akaishi
, Yasushi Suzuki
, et al.
·
BMC Neurology
·
43
PDF
Glucocorticoid Therapy and the Risk of Infection in Patients With Newly Diagnosed Autoimmune Disease
2013
·
Kiyoshi Migita
, Yasuharu Sasaki
, et al.
·
Medicine
·
41
PDF
Therapeutic Responses to Efgartigimod for Generalized Myasthenia Gravis in Japan
2024
·
Shigeaki Suzuki
, Akiyuki Uzawa
, et al.
·
Neurology Clinical Practice
·
40
Japan MG registry: Chronological surveys over 10 years
2022
·
Shigeaki Suzuki
, Masayuki Masuda
, et al.
·
Clinical and Experimental Neuroimmunology
·
40
PDF
Five-year follow-up with low-dose tacrolimus in patients with myasthenia gravis
2010
·
Naoya Minami
, Naoto Fujiki
, et al.
·
Journal of the Neurological Sciences
·
33
Real‐world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis
2024
·
Daiki Tokuyasu
, Shigeaki Suzuki
, et al.
·
Annals of Clinical and Translational Neurology
·
29
Oral corticosteroid dosing regimen and long-term prognosis in generalised myasthenia gravis: a multicentre cross-sectional study in Japan
2017
·
Tomihiro Imai
, Kimiaki Utsugisawa
, et al.
·
Journal of Neurology Neurosurgery & Psychiatry
·
25
PDF
Suppression of IL-10 production by calcitriol in patients with multiple sclerosis
2014
·
Masaaki Niino
, Toshiyuki Fukazawa
, et al.
·
Journal of Neuroimmunology
·
24
Fingolimod induces BAFF and expands circulating transitional B cells without activating memory B cells and plasma cells in multiple sclerosis
2017
·
Yusei Miyazaki
, Masaaki Niino
, et al.
·
Clinical Immunology
·
23
Hot Water Epilepsy with Pineal Cyst and Cavum Septi Pellucidi
1993
·
Yasutaka Tajima
, Naoya Minami
, et al.
·
Psychiatry and Clinical Neurosciences
·
15
Impact of Early Treatment with Intravenous High-Dose Methylprednisolone for Ocular Myasthenia Gravis
2023
·
Akiyuki Uzawa
, Shigeaki Suzuki
, et al.
·
Neurotherapeutics
·
12
PDF
Fingolimod suppresses bone resorption in female patients with multiple sclerosis
2016
·
Yusei Miyazaki
, Masaaki Niino
, et al.
·
Journal of Neuroimmunology
·
12
Usefulness of 11C-methionine-positron emission tomography for the diagnosis of progressive multifocal leukoencephalopathy
2014
·
Shinichi Shirai
, Ichiro Yabe
, et al.
·
Journal of Neurology
·
12
PDF
Association of serum vitamin D levels in J apanese patients with multiple sclerosis
2013
·
Masaaki Niino
, Toshiyuki Fukazawa
, et al.
·
Clinical and Experimental Neuroimmunology
·
12
Cutoffs on severity metrics for minimal manifestations or better status in patients with generalized myasthenia gravis
2024
·
Genya Watanabe
, Yoshiki Takai
, et al.
·
Frontiers in Immunology
·
11
PDF
Taste disorders and alopecia in myasthenia gravis
2024
·
Akiyuki Uzawa
, Shigeaki Suzuki
, et al.
·
BMC Neurology
·
11
PDF
Recurrent Brainstem Lesions Mimicking Infarctions in an Elderly Patient with Neuromyelitis Optica Spectrum Disorder
2012
·
Masaaki Niino
, Haruo Uesugi
, et al.
·
Internal Medicine
·
11
PDF
Immunotherapy for ocular myasthenia gravis: an observational study in Japan
2023
·
Tomoko Narita
, Shunya Nakane
, et al.
·
Therapeutic Advances in Neurological Disorders
·
10
Stages of brain volume loss and performance in the Brief International Cognitive Assessment for Multiple Sclerosis
2022
·
Yusei Miyazaki
, Masaaki Niino
, et al.
·
Multiple Sclerosis and Related Disorders
·
10
Clinical features and outcomes of patients with muscle-specific kinase antibody-positive myasthenia gravis in Japan
2023
·
Manato Yasuda
, Akiyuki Uzawa
, et al.
·
Journal of Neuroimmunology
·
9
Show more works
View as search
Works count:
64
Citation count:
1,089
H-index:
15
I10-index:
24
Year
Topic
Type